Open navigation
Search
Search

Select your region

Christoph Lächler
Partner

Dr. Christoph Lächler

Rechtsanwalt

Languages
  • German
  • English
  • French
Social media

Christoph Lächler specialises in private equity and M&A transactions, advising German and international investors and companies on cross-border company acquisitions and sales, add-on transactions, joint ventures and other cooperation agreements. His clients include strategic investors as well as family equity investors. Christoph also has special expertise in the life Sciences and healthcare sectors with a focus on advising on M&A transactions related to outpatient and inpatient services.

Christoph joined CMS in 2007 and was made partner in 2017. Alongside his legal practice, he has been a lecturer at Steinbeis School of International Business and Entrepreneurship since 2011.

Awards & Recognitions
01
  • Quote
    Listed for Corporate
    Deutschlands beste Anwälte 2025 – Handelsblatt in Kooperation mit Best Lawyers
  • Quote
    Listed for Mergers and Acquisitions
    Deutschlands beste Anwälte 2025 – Handelsblatt in Kooperation mit Best Lawyers
  • Quote
    „Christoph Lächler: Hohes Maß an Engagement und gutes wirtschaftliches Verständnis.“, Mandant
    The Legal 500 Deutschland, 2025
  • Quote
    Listed for Corporate
    Deutschlands beste Anwälte 2024 – Handelsblatt in Kooperation mit Best Lawyers
  • Quote
    Listed for Mergers and Acquisitions
    Deutschlands beste Anwälte 2024 – Handelsblatt in Kooperation mit Best Lawyers
  • Quote
    ‘Very good specialist knowledge combined with a very pragmatic, solution-oriented approach. Respective teams led by Christoph Lächler are deeply anchored in the healthcare sector and have years of experience in this field.’, client
    The Legal 500 EMEA, 2024
  • Quote
    Listed for Corporate
    Deutschlands beste Anwälte 2023 – Handelsblatt in Kooperation mit Best Lawyers
  • Quote
    "Very competent, quick-reacting contact persons, especially Christoph Lächler, who has very sound legal knowledge and uses it optimally.", client
    The Legal 500 EMEA, 2022
  • Quote
    Leading lawyer for mergers & acquisitions
    Kanzleimonitor 2021, 2022
  • Quote
    Leading lawyer for mergers & acquisitions
    Kanzleimonitor 2020, 2021
  • Quote
    "Very competent, quick-reacting contact persons, especially Christoph Lächler, who has very sound legal knowledge and uses it optimally.", client
    The Legal 500 EMEA, 2022

Publications

  • “Getting the Deal Through: Healthcare M&A, Country Report Germany, September 2019, Law Business Research Ltd.” (together with Dr Roland Wiring und Daniel Mahn)
  • Familienverfassung und Family Governance, in: von Rechenberg/Thies/Wiechers (Hrsg.), Handbuch Familienunternehmen und Unternehmerfamilien, Stuttgart 2016
  • Kommentierung zum SE-Konzernrecht, in: Lutter/Hommelhoff/Teichmann (Hrsg.), SE-Kommentar, 2. Aufl., Köln, 2015 (together with Prof. Dr Dr h.c. mult. Peter Hommelhoff)
  • Förder- und Schutzrecht für den SE-Konzern, AG 2014, p. 257 ff. (together with Prof. Dr Dr h.c. mult. Peter Hommelhoff)
  • Das Konzernrecht der Europäischen Gesellschaft (SE): Unter besonderer Berücksichtigung der Mitgliedstaaten Deutschland, Frankreich, England und Polen 2007, Baden-Baden
  • Funktion und Umfang des Regelungsbereichs der SE-Verordnung, NZG 2005, p. 381 ff. (together with K. Oplustil)

Education

  • 2007: Second state examination in law
  • Trainee lawyer at Ellwangen Regional Court including placements in Stuttgart and New York
  • PhD; thesis on the group law of the Societas Europaea (SE) under the supervision of Prof. Dr. Dr. Dres. h.c. Peter Hommelhoff, European Post Graduate Programme at the University of Heidelberg
  • 2003: First state examination in law
  • Law and economics studies at the University of Heidelberg

Insights by Christoph

CMS advises SYNLAB on the sale of synlab slovakia s.r.o. to Unilabs Group

11 Feb 2026 2 min read

CMS advises Sunrise Medical on the acquisition of Ergoflix Group

23 Jan 2026 2 min read

CMS advises Jamco Corporation on the acquisition of Schüschke Holding GmbH

23 Jan 2026 1 min read

CMS Reception at JP Morgan Healthcare Conference Week 2026

15 Jan 2026
Back to top Back to top